Association between survival in patients with primary invasive breast cancer and computer aided MRI

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 1, 2013, Pages 146-155

  Dietzel, Matthias ^a,b   Zoubi, Ramy ^a   Vag, Tibor ^c   Gajda, Mieczyslaw ^a   Runnebaum, Ingo B ^a   Kaiser, Werner A ^a   Baltzer, Pascal A ^a,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

breast; magnetic resonance imaging; mortality; neoplasms primary; prognosis; survival

Indexed keywords

CONTRAST MEDIUM; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; TRASTUZUMAB;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDULLARY CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT CARE; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR BLEEDING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGRESSION ANALYSIS; SOFTWARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872875852     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23812     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC,. Early breast cancer. Lancet 2009; 373: 1463-1479.
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-1717.
4. Kreienberg R, Kopp I, Albert U, et al. Interdisciplinary S3-guideline for the diagnosis, therapy and follow up of breast cancer. In German. Munich: W. Zuckschwerdt Verlag; 2008.
5. Donegan WL,. Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 1997; 47: 28-51.
6. DeMartini W, Lehman C,. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19: 143-150.
7. Kaiser W,. MRI of the female breast. First clinical results. Arch Int Physiol Biochim 1985; 93: 67-76.
8. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-3258.
9. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-1303.
10. Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010; 46: 1296-1316.
11. Bone B, Szabo BK, Perbeck LG, Veress B, Aspelin P,. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003; 44: 373-378.
12. Johansen R, Jensen LR, Rydland J, et al. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging 2009; 29: 1300-1307.
13. Pickles MD, Manton DJ, Lowry M, Turnbull LW,. Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy. Eur J Radiol 2009; 71: 498-505.
14. Baltzer PAT, Vag T, Dietzel M, Camara O, Gajda M, Kaiser WA,. Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer. Eur Radiol 2010; 20: 1563-1571.
15. Dietzel M, Baltzer PA, Vag T, et al. Potential of MR mammography to predict tumor grading of invasive breast cancer. Rofo 2011; 183: 826-833.
16. Leach MO,. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 2001; 3: 22-27.
17. Stomper PC, Winston JS, Herman S, Klippenstein DL, Arredondo MA, Blumenson LE,. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997; 45: 39-46.
18. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10: 260-266.
19. Breast imaging reporting and data system atlas (BI-RADS atlas), 1st ed. Reston, VA: American College of Radiology; 2003.
20. Baltzer PA, Freiberg C, Beger S, et al. Clinical MR-mammography: are computer-assisted methods superior to visual or manual measurements for curve type analysis? A systematic approach. Acad Radiol 2009; 16: 1070-1076.
21. Baltzer PA, Renz DM, Kullnig PE, Gajda M, Camara O, Kaiser WA,. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis? Acad Radiol 2009; 16: 435-442.
22. Heldahl MG, Bathen TF, Rydland J, et al. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis. Acta Radiol 2010; 51: 604-612.
23. Li SP, Makris A, Beresford MJ, et al. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy. Radiology 2011; 260: 68-78.
24. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 2003; 226: 24-28.
25. Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol 2010; 17: 2395-2400.
26. Sardanelli F, Bacigalupo L, Carbonaro L, et al. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard? Radiol Med 2008; 113: 439-451.
27. Edge S, Byrd D, Carducci M, Wittekind C,. TNM classification of malignant tumours, 7th ed. New York: Springer; 2009.
28. Elston CW, Ellis IO,. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
29. Mann RM, Kuhl CK, Kinkel K, Boetes C,. Breast MRI: guidelines from the European society of breast imaging. Eur Radiol 2008; 18: 1307-1318.
30. Baltzer PAT, Renz DM, Kullnig PE, Gajda M, Camara O, Kaiser WA,. Application of computer-aided diagnosis (CAD) in MR-mammography (MRM): do we really need whole lesion time curve distribution analysis? Acad Radiol 2009; 16: 435-442.
31. Baltzer PA, Dietzel M, Vag T, et al. Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography? Rofo 2010; 182: 254-260.
32. Michaelson JS, Silverstein M, Wyatt J, et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002; 95: 713-723.
33. Carter CL, Allen C, Henson DE,. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-187.
34. Greene FL,. AJCC cancer staging handbook, 6th ed. New York. Springer: Springer; 2002.
35. Kaiser WA, Zeitler E,. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989; 170: 681-686.
36. Weidner N, Semple JP, Welch WR, Folkman J,. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
37. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-1887.
38. Folkman J, Merler E, Abernathy C, Williams G,. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971; 133: 275-288.
39. Baltzer PA, Vag T, Dietzel M, et al. Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer. Eur Radiol 2010; 20: 1563-1571.
40. Kuhl C,. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007; 244: 356-378.
41. Fewtrell MS, Kennedy K, Singhal A, et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies? Arch Dis Child 2008; 93: 458-461.